title: Confounding due to changing background risk in adaptively randomized trials.
abstract: BACKGROUND
  While adaptive trials tend to improve efficiency, they are also subject to some unique biases.
  
  
  OBJECTIVE
  We address a bias that arises from adaptive randomization in the setting of a time trend in disease incidence.
  
  
  METHODS
  We use a potential-outcome model and directed acyclic graphs to illustrate the bias that arises from a changing subject allocation ratio with a concurrent change in background risk.
  
  
  RESULTS
  In a trial that uses adaptive randomization, time trends in risk can bias the crude effect estimate obtained by naively combining the data from the different stages of the trial. We illustrate how the bias arises from an interplay of departures from exchangeability among groups and the changing randomization proportions.
  
  
  CONCLUSIONS
  We focus on risk-ratio and risk-difference analysis.
  
  
  CONCLUSIONS
  Analysis of trials using adaptive randomization should involve attention to or adjustment for possible trends in background risk. Numerous modeling strategies are available for that purpose, including stratification, trend modeling, inverse-probability-of-treatment weighting, and hierarchical regression.
authors: Gertner Institute for Epidemiology and Health Policy Research, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel. aril@alum.mit.edu
authors: Ari M
authors: AM
authors: Lipsky
authors: Sander
authors: S
authors: Greenland
references: J Biopharm Stat. 2006 May;16(3):275-83; discussion 285-91, 293-8, 311-2
references: 16724485
references: Stat Med. 1994 May 30;13(10):989-99
references: 8073203
references: J Biopharm Stat. 2007;17(6):1227-38
references: 18027228
references: Epidemiology. 1999 Jan;10(1):37-48
references: 9888278
references: Nat Biotechnol. 2007 Mar;25(3):287-92
references: 17344876
references: Stat Med. 2000 Aug 15;19(15):2067-75
references: 10900452
references: Stat Med. 1988 Jun;7(6):629-37
references: 3043621
references: Orphanet J Rare Dis. 2008 May 02;3:11
references: 18454853
references: J Chronic Dis. 1987;40 Suppl 2:17S-24S
references: 3667863
references: Epidemiology. 2000 Sep;11(5):550-60
references: 10955408
references: Biomedicine. 1978 Sep;28 Spec No:40-1
references: 363193
references: Int J Epidemiol. 2000 Feb;29(1):158-67
references: 10750618
references: Nat Rev Drug Discov. 2006 Jan;5(1):27-36
references: 16485344
references: Br J Clin Pharmacol. 1982 Apr;13(4):469-80
references: 7066161
references: J Biopharm Stat. 2005;15(4):575-91
references: 16022164
references: Stat Sci. 2007;22(4):569-573
references: 18516239